Static Chart Toleranzia AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-06-20 pm EDT			5-day change	1st Jan Change
0.64 ^SEK	+0.31%		0.00%	+49.53%

May. 31	Toleranzia AB Conducts Successful Safety Study of TOL2 in Blood Samples from Patients with Myasthenia gravis	CI
May. 20	Toleranzia AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Duration

Period